Related Experiment Video

Updated: Aug 12, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Treating serious infections: focus on cefepime

Annie Wong-Beringer1

  • 1School of Pharmacy, University of Southern California, Los Angeles, California 90089, USA.

Pharmacotherapy
|December 9, 2004
PubMed

Insights

Antibiotic resistance threatens effective treatment of serious infections. This review covers infection causes, resistance threats, and the impact of inadequate empiric therapy, focusing on cefepime for pneumonia and febrile neutropenia.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pharmacology

Background:

  • Antibiotic resistance in key pathogens diminishes the effectiveness of broad-spectrum antibiotics for treating severe infections.
  • Emerging resistance poses a significant global health threat, complicating empiric treatment strategies.
  • Inadequate empiric therapy negatively impacts patient outcomes and hospital environments.

Purpose of the Study:

  • To provide an overview of the etiology and emerging resistance patterns of serious infections.
  • To review the adverse effects of insufficient empiric treatment on patients and healthcare settings.
  • To discuss the use of cefepime in treating specific infections like hospital-acquired pneumonia and febrile neutropenia.

Main Methods:

  • Literature review on antibiotic resistance, infection etiology, and treatment outcomes.
  • Analysis of the impact of empiric antibiotic therapy on patient prognosis.
  • Case discussion of cefepime efficacy in pneumonia and febrile neutropenia.

Main Results:

  • Growing antibiotic resistance is a major challenge in managing serious infections.
  • Suboptimal empiric treatment leads to poorer patient outcomes and contributes to resistance spread.
  • Cefepime demonstrates clinical utility in treating specific serious infections.

Conclusions:

  • Addressing antibiotic resistance is crucial for preserving therapeutic options.
  • Optimizing empiric treatment strategies is essential for improving patient care and infection control.
  • Cefepime remains a valuable agent for specific indications in the context of evolving resistance patterns.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...